Long-term immune changes after COVID-19 and the effect of BCG vaccination and latent infections on disease severity

. 2025 ; 14 (7) : e70041. [epub] 20250627

Status PubMed-not-MEDLINE Jazyk angličtina Země Austrálie Médium electronic-ecollection

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid40584929

OBJECTIVES: Several years after the COVID-19 pandemic, the impact of SARS-CoV-2 on immunity and the potential protective role of Bacillus Calmette-Guérin (BCG) vaccination through trained immunity remain a subject of investigation. This study aimed to determine the long-term impact of SARS-CoV-2 on immune cells and the association between BCG vaccination, latent infections and COVID-19 severity and sepsis progression. METHODS: We conducted a prospective analysis of patients who recovered from mild/severe/critical COVID-19 (n = 97, 3-17 months after COVID-19) and sepsis patients (n = 64). First, we assessed the impact of COVID-19 and its severity on immune cell frequencies and expression of functional markers. Further, we analysed plasma titres of anti-Toxoplasma gondii/cytomegalovirus/BCG antibodies and their association with COVID-19 severity and sepsis outcome. To examine monocyte responses to secondary challenge, monocytes isolated from COVID-19 convalescent patients, BCG vaccinated and unvaccinated volunteers were stimulated with SARS-CoV-2 and LPS. RESULTS: Post-COVID-19 patients showed immune dysregulation regardless of disease severity characterised by altered expression of activation and functional markers in myeloid (CD39, CD64, CD85d, CD11b) and lymphoid cells (CD39, CD57, TIGIT). Strikingly, post-critical COVID-19 patients showed elevated expression of CD57 in CD8+ T cells compared to other severity groups. A trend toward improved outcomes in BCG-seropositive COVID-19/sepsis patients was observed, although this may be confounded by age differences between groups. In contrast, the monocyte response to stimulation appeared unaffected by COVID-19 severity. CONCLUSION: These findings highlight the long-term alterations of immune cells in post-COVID-19 patients, emphasising the substantial impact of COVID-19 on immune function.

Zobrazit více v PubMed

Kratzer B, Gattinger P, Trapin D PubMed

Yin K, Peluso MJ, Luo X PubMed PMC

Taeschler P, Adamo S, Deng Y PubMed PMC

Wen W, Su W, Tang H PubMed PMC

Lage SL, Amaral EP, Hilligan KL PubMed PMC

Netea MG, Giamarellos‐Bourboulis EJ, Dominguez‐Andres J PubMed PMC

Benn CS, Netea MG, Selin LK, Aaby P. A small jab – a big effect: nonspecific immunomodulation by vaccines. Trends Immunol 2013; 34: 431–439. PubMed

Netea MG, Quintin J, van der Meer JW. Trained immunity: a memory for innate host defense. Cell Host Microbe 2011; 9: 355–361. PubMed

Netea MG, Dominguez‐Andres J, Barreiro LB PubMed PMC

Berg MK, Yu Q, Salvador CE, Melani I, Kitayama S. Mandated Bacillus Calmette‐Guérin (BCG) vaccination predicts flattened curves for the spread of COVID‐19. Sci Adv 2020; 6: eabc1463. PubMed PMC

Hegarty PK, Sfakianos JP, Giannarini G, DiNardo AR, Kamat AM. COVID‐19 and Bacillus Calmette‐Guérin: what is the link? Eur Urol Oncol 2020; 3: 259–261. PubMed PMC

O'Neill LAJ, Netea MG. BCG‐induced trained immunity: can it offer protection against COVID‐19? Nat Rev Immunol 2020; 20: 335–337. PubMed PMC

Moorlag S, Taks E, Ten Doesschate T PubMed PMC

Sinha S, Ajayababu A, Thukral H PubMed PMC

Tsilika M, Taks E, Dolianitis K PubMed PMC

Santos AP, Werneck GL, Dalvi APR PubMed PMC

Kuhtreiber WM, Hostetter ER, Wolfe GE PubMed PMC

Pittet LF, Messina NL, Orsini F PubMed PMC

Madsen AMR, Schaltz‐Buchholzer F, Nielsen S PubMed

Koekenbier EL, Fohse K, van de Maat JS PubMed PMC

Ten Doesschate T, van der Vaart TW, Debisarun PA PubMed PMC

Upton CM, van Wijk RC, Mockeliunas L PubMed PMC

Dos Santos PCP, Messina NL, de Oliveira RD PubMed PMC

Pittet LF, Messina NL, Curtis N. BCG to protect against COVID‐19 in health care workers. Reply. N Engl J Med 2023; 389: 191–192. PubMed

Aaby P, Netea MG, Benn CS. Beneficial non‐specific effects of live vaccines against COVID‐19 and other unrelated infections. Lancet Infect Dis 2023; 23: e34–e42. PubMed PMC

Ehmen HG, Luder CGK. Long‐term impact of PubMed PMC

Barton ES, White DW, Cathelyn JS PubMed

Souza MC, Fonseca DM, Kanashiro A PubMed PMC

Quintin J, Cheng SC, van der Meer JW, Netea MG. Innate immune memory: towards a better understanding of host defense mechanisms. Curr Opin Immunol 2014; 29: 1–7. PubMed

Kleinnijenhuis J, Quintin J, Preijers F PubMed PMC

Quintin J, Saeed S, Martens JHA PubMed PMC

Giamarellos‐Bourboulis EJ, Tsilika M, Moorlag S PubMed PMC

Brook B, Harbeson DJ, Shannon CP PubMed PMC

Schaltz‐Buchholzer F, Bjerregard Oland C, Berendsen M PubMed

Andrejcinova I, Blazkova G, Papatheodorou I PubMed PMC

Singer M, Deutschman CS, Seymour CW PubMed PMC

Karakike E, Giamarellos‐Bourboulis EJ, Kyprianou M PubMed PMC

Vuscan P, Kischkel B, Joosten LAB, Netea MG. Trained immunity: general and emerging concepts. Immunol Rev 2024; 323: 164–185. PubMed

Arnaout M. Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood 1990; 75: 1037–1050. PubMed

Pulte ED, Broekman MJ, Olson KE PubMed PMC

Lord JM, Veenith T, Sullivan J PubMed PMC

Chong M, Yin T, Chen R PubMed PMC

Tian J, Ashique AM, Weeks S PubMed

Malengier‐Devlies B, Filtjens J, Ahmadzadeh K PubMed PMC

De Zuani M, Laznickova P, Tomaskova V PubMed PMC

Du RH, Liang LR, Yang CQ PubMed PMC

Brenchley JM, Karandikar NJ, Betts MR PubMed

Files JK, Boppana S, Perez MD PubMed PMC

Ke J, Huang S, He Z, Lei S, Lin S, Duan M. TIGIT regulates T cell inflammation in airway inflammatory diseases. Inflammation 2024; 48: 15–24. PubMed

Nikolich‐Zugich J, Cicin‐Sain L, Collins‐McMillen D PubMed PMC

Wilking H, Thamm M, Stark K, Aebischer T, Seeber F. Prevalence, incidence estimations, and risk factors of PubMed PMC

Kolbekova P, Kourbatova E, Novotna M, Kodym P, Flegr J. New and old risk‐factors for PubMed

Lachmann R, Loenenbach A, Waterboer T PubMed PMC

Svobodova V, Literak I. Prevalence of IgM and IgG antibodies to PubMed

Flegr J. Toxoplasmosis is a risk factor for acquiring SARS‐CoV‐2 infection and a severe course of COVID‐19 in the Czech and Slovak population: a preregistered exploratory internet cross‐sectional study. Parasit Vectors 2021; 14: 508. PubMed PMC

Jankowiak L, Rozsa L, Tryjanowski P, Moller AP. A negative covariation between toxoplasmosis and COVID‐19 with alternative interpretations. Sci Rep 2020; 10: 12512. PubMed PMC

Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: global status of PubMed

Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004; 363: 1965–1976. PubMed

de Castro MJ, Pardo‐Seco J, Martinon‐Torres F. Nonspecific (heterologous) protection of neonatal BCG vaccination against hospitalization due to respiratory infection and sepsis. Clin Infect Dis 2015; 60: 1611–1619. PubMed

Schaltz‐Buchholzer F, Biering‐Sorensen S, Lund N PubMed

Taks EJM, Moorlag S, Netea MG, van der Meer JWM. Shifting the immune memory paradigm: trained immunity in viral infections. Annu Rev Virol 2022; 9: 469–489. PubMed

Silva TF, Concato VM, Tomiotto‐Pellissier F PubMed PMC

de Chaisemartin C, de Chaisemartin L. Bacille Calmette‐Guérin vaccination in infancy does not protect against coronavirus disease 2019 (COVID‐19): evidence from a natural experiment in Sweden. Clin Infect Dis 2021; 72: e501–e505. PubMed PMC

Khoshnood S, Arshadi M, Akrami S PubMed PMC

Organization WH . Clinical management of COVID‐19: interim guidance, 27 May 2020. World Health Organization. 2020. https://iris.who.int/handle/10665/332196 (Accessed May 20, 2025).

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...